16 response was also higher in the patients treated at 600 mg (33%) as compared to the patients treated at 400 mg (16%, p=0.0220).
Ravivastus esines sagedamini patsientidel, keda raviti annusega 600 mg (33%) võrreldes patsientidega, keda raviti annusega 400 mg (16%, p=0, 0220).